GenScript offers comprehensive solutions of services and products for the development of Antibody therapy, Gene therapy, Cell therapy, Vaccines, and IVD. We provide end-to-end solutions from target discovery and validation, lead identification, and optimization to pre-clinical and clinical development and production.
Antibody therapy is a type of medical treatment that harnesses the power of the immune system to target and eliminate specific proteins or cells that cause disease.
Key GenScript offerings for this market segment are gene synthesis, CRISPR services and products, antigen peptide synthesis, protein expression services, antibody development and optimization platforms, and others.
Gene therapy is a medical approach that involves the introduction of genetic material into a patient's cells to treat or prevent disease.
Key GenScript offerings for this market segment are gene synthesis, CRISPR gene editing, mRNA IVT services, plasmid and viral vector production, and others.
Cell therapy is a type of medical treatment that involves the use of living cells to help repair or replace damaged tissues within the body.
Key GenScript offerings include gene synthesis, plasmid, and virus vector services, antigen peptide synthesis, protein expression services, mRNA IVT service, and others.
Vaccines are biological preparations that help protect individuals from infectious diseases by stimulating the immune system to recognize and fight specific pathogens.
Key GenScript offerings include gene synthesis, plasmid, virus vector services, antigen peptide synthesis, protein expression services, mRNA IVT service, and others.
In vitro diagnostics (IVD) are medical tests performed on biological samples outside the body, such as blood, urine, or tissue. These tests are critical in diagnosing diseases, monitoring treatment progress, and determining patient eligibility for specific therapies.
Key GenScript offerings include primer and probe synthesis, protein expression services, Antibody development services and others.
Plant genetic engineering is the manipulation of plant DNA to produce desired traits. This technology has the potential to revolutionize agriculture by creating plants with improved resistance to pests, diseases, and environmental stressors.
Key offerings in this area are: Variant gene libraries, gene editing, and mutagenesis tools
Synthetic biology is a field of science that combines biology and engineering to design and create new biological systems with specific functions.
Key offerings in this area are Gene synthesis, Precision mutant libraries, gene editing, antibody generation and others.
GenScript Biotech Corporation is a well-recognized biotechnology company. Based on our proprietary gene synthesis technology and other technologies and know-how on life-science research and applications, we have established four major platforms:
The Life Science Group has been inspired by the mission "Make People and Nature Healthier through Biotechnology" since it was founded in 2002. Our clients' business needs are the Group’s priority and the ultimate cornerstone for pursuing its long-term development. We have been improving our clients' competitiveness by providing high quality, fast-delivery, and cost-effective services and products. Internally, we focus on streamlining our operational workflows and procedures with the aim to strive for the highest quality of end-to-end delivery. Externally, we actively promote the value of strategic collaboration with business partners with the vision to build up a healthy biotech ecosystem.